BMC Cancer

1. DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
   Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
   BMC Cancer. 2024;24:240.
   

   >> Share

   
   
2. QIU P, Guo Q, Pan K, Lin J, et al
   Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
   BMC Cancer. 2024;24:235.
   

   >> Share

   
   
3. YASSIN-KASSAB A, Chatterjee S, Khan N, Wang N, et al
   p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
   BMC Cancer. 2024;24:233.
   

   >> Share

   
   
4. YU XW, She PW, Chen FC, Chen YY, et al
   Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
   BMC Cancer. 2024;24:230.
   

   >> Share

   
   
5. TAN R, Zhu X, Sun Y, Yang S, et al
   The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
   BMC Cancer. 2024;24:225.
   

   >> Share

   
   
6. ALMANGUSH A, Hagstrom J, Haglund C, Kowalski LP, et al
   The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
   BMC Cancer. 2024;24:213.
   

   >> Share

   
   
7. JAKSTAS T, Bartnykaite A, Padervinskis E, Vegiene A, et al
   The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
   BMC Cancer. 2024;24:214.
   

   >> Share

   
   
8. WU Y, Chen W, Miao H, Xu T, et al
   SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
   BMC Cancer. 2024;24:210.
   

   >> Share

   
   
9. GONG L, Li P, Liu J, Liu Y, et al
   A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.
   BMC Cancer. 2024;24:244.
   

   >> Share

   
   
10. YANG Y, Tan H, Lu Y, Mei J, et al
    Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:249.
    

    >> Share

    
    
11. HUANG X, Chen X, Wan G, Yang D, et al
    Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
    BMC Cancer. 2024;24:245.
    

    >> Share

    
    

    
    BMC Surg

12. ZOU WW, Mok HP, Zhu QK, Luo J, et al
    Perioperative corticosteroids for reducing postoperative complications following esophagectomy: an updated systematic review and meta-analysis.
    BMC Surg. 2024;24:57.
    

    >> Share

    
    

    
    Br J Cancer

13. SHANG Q, Jiang Y, Wan Z, Peng J, et al
    The clinical implication and translational research of OSCC differentiation.
    Br J Cancer. 2024;130:660-670.
    

    >> Share

    
    
14. CHENG Z, Johar A, Nilsson M, Schandl A, et al
    Cancer-related fatigue trajectories up to 5 years after curative treatment for oesophageal cancer.
    Br J Cancer. 2024;130:628-637.
    

    >> Share

    
    

    
    Cancer

15. HO AL, Foster NR, Deraje Vasudeva S, Katabi N, et al
    A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
    Cancer. 2024;130:702-712.
    

    >> Share

    
    
16. CHOI H, Cho SW, Kim HH, Yi KH, et al
    Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma.
    Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
    

    >> Share

    
    

    
    Clin Cancer Res

17. KIM YH, Yoon SJ, Kim M, Kim HH, et al
    Integrative multi-omics analysis reveals different metabolic phenotypes based on molecular characteristics in thyroid cancer.
    Clin Cancer Res. 2023 Dec 13. doi: 10.1158/1078-0432.CCR-23-2025.
    

    >> Share

    
    

    
    Clin Nucl Med

18. LIANG Z, Li W
    Uptake of 99mTc-DTPA in Bone Metastases From Follicular Thyroid Carcinoma.
    Clin Nucl Med. 2024 Feb 7. doi: 10.1097/RLU.0000000000005100.
    

    >> Share

    
    
19. LATGE A, Krim M, Vija L, Ysebaert L, et al
    Diffuse Bone Uptake of 131I and Effect on Blood Counts in a Patient With Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia.
    Clin Nucl Med. 2024 Feb 12. doi: 10.1097/RLU.0000000000005119.
    

    >> Share

    
    

    
    Gastrointest Endosc

20. HABER G
    What goes around, comes around: circumferential endoscopic submucosal dissection and stricture.
    Gastrointest Endosc. 2024;99:346-348.
    

    >> Share

    
    
21. XIANG AY, Wang KH, Su W, Tan T, et al
    Endoscopic resection of giant esophageal subepithelial lesions: experience from a large tertiary center.
    Gastrointest Endosc. 2024;99:358-370.
    

    >> Share

    
    
22. MOTOMURA D, Bechara R
    Complete circumferential endoscopic submucosal dissection for early Barrett's neoplasia.
    Gastrointest Endosc. 2024;99:337-345.
    

    >> Share

    
    

    
    Head Neck

23. KONO M, Wakisaka R, Komatsuda H, Hayashi R, et al
    Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer.
    Head Neck. 2024 Feb 23. doi: 10.1002/hed.27703.
    

    >> Share

    
    
24. LU HJ, Hsieh MC, Wang HM, Hsieh JC, et al
    Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database.
    Head Neck. 2024 Feb 22. doi: 10.1002/hed.27681.
    

    >> Share

    
    
25. QI Y, Shao W, Gao J, Ni N, et al
    Monoamine oxidase B inhibits epithelial-mesenchymal transition and trigger apoptosis via targeting ERK1/2 signaling pathway in head and neck squamous cell carcinoma.
    Head Neck. 2024 Feb 20. doi: 10.1002/hed.27697.
    

    >> Share

    
    
26. JIN YN, Xiao ZW, Yao W, Yu J, et al
    Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.
    Head Neck. 2024 Feb 17. doi: 10.1002/hed.27689.
    

    >> Share

    
    
27. ZHU KX, Ding T, E YM, Yang HW, et al
    Effect of waiting time for radiotherapy after last induction chemotherapy on prognosis of locally advanced nasopharyngeal carcinoma.
    Head Neck. 2024 Feb 17. doi: 10.1002/hed.27680.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

28. DE BRUYCKER A, De Neve W, Daisne JF, Vercauteren T, et al
    Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase II trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
    

    >> Share

    
    
29. ADAM DP, Grudzinski JJ, Marsh IR, Hill PM, et al
    Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

30. KWON H, Han KD, Moon SJ, Park SE, et al
    Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
    

    >> Share

    
    
31. MAINO F, Botte M, Dalmiglio C, Valerio L, et al
    Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
    J Clin Endocrinol Metab. 2024;109:722-729.
    

    >> Share

    
    
32. DAI P, Zhao W, Zheng X, Luo H, et al
    Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant.
    J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
    

    >> Share

    
    
33. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    

    >> Share

    
    

    
    J Laryngol Otol

34. METCALFE C, Oh S, Glazzard N, Ross E, et al
    A novel remote assessment pathway to streamline the management of two-week-wait suspected head and neck cancer referrals: a prospective analysis of 660 patients.
    J Laryngol Otol. 2024 Jan 19:1-5. doi: 10.1017/S002221512400015.
    

    >> Share

    
    

    
    J Nucl Med

35. KOVACS DG, Ladefoged CN, Andersen KF, Brittain JM, et al
    Clinical Evaluation of Deep Learning for Tumor Delineation on (18)F-FDG PET/CT of Head and Neck Cancer.
    J Nucl Med. 2024 Feb 22:jnumed.123.266574. doi: 10.2967/jnumed.123.266574.
    

    >> Share

    
    

    
    Laryngoscope

36. HEIRMAN AN, de Kort DP, Petersen JF, Al-Mamgani A, et al
    Decisional Conflict in Patients with Advanced Laryngeal Carcinoma: A Multicenter Study.
    Laryngoscope. 2024 Feb 17. doi: 10.1002/lary.31336.
    

    >> Share

    
    
37. GOODYEAR K, Roelofs KA, Su-Velez BM, Cohen LM, et al
    A Minimally Invasive Endoscopic Transnasal and Transorbital Approach to Sinonasal Tumor Resection.
    Laryngoscope. 2024;134:1308-1312.
    

    >> Share

    
    
38. KEY S, Chia C, Hasan Z, Sundaresan P, et al
    Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
    Laryngoscope. 2024;134:1042-1053.
    

    >> Share

    
    
39. SCHILLING C, Collins L, Farrow A, McGurk M, et al
    Incidental Thyroid Tissue in Sentinel Nodes From Oral Squamous Cell Carcinoma.
    Laryngoscope. 2024;134:1278-1281.
    

    >> Share

    
    
40. LIU GS, Berry GJ, Soltys SG, Blevins NH, et al
    Glomangiopericytoma Presenting as a Middle Ear Mass.
    Laryngoscope. 2023 Aug 24. doi: 10.1002/lary.30987.
    

    >> Share

    
    
41. GUO T, Jang SS, Ogawa R, Davis M, et al
    Fluorescent Guided Sentinel Lymph Mapping of the Oral Cavity with Fluorescent-Labeled Tilmanocept.
    Laryngoscope. 2024;134:1299-1307.
    

    >> Share

    
    

    
    Oral Oncol

42. CHEN QY, Guo SS, Luo Y, Qu S, et al
    Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
    Oral Oncol. 2024;151:106723.
    

    >> Share

    
    
43. FANCELLO G, Jiang S, Licci G, Gallo O, et al
    Comments on the article titled "Factors associated with unknown primary status in head and neck squamous cell carcinoma": Is the N status the overlooked elephant in the room?
    Oral Oncol. 2024;151:106727.
    

    >> Share

    
    
44. HU J, Huang Q, Hu W, Liang F, et al
    Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
    Oral Oncol. 2024;151:106683.
    

    >> Share

    
    

    
    PLoS One

45. NGUYEN V, Schrank TP, Major MB, Weissman BE, et al
    ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas.
    PLoS One. 2024;19:e0297741.
    

    >> Share

    
    

    
    Radiother Oncol

46. LINGE A, Patil S, Grosser M, Lohaus F, et al
    The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts.
    Radiother Oncol. 2024;191:110055.
    

    >> Share

    
    
47. ZHONG Y, Lyu X, Huang M, Zheng L, et al
    Sole brachytherapy for inoperable, recurrent, and irradiated salivary gland cancer.
    Radiother Oncol. 2024;190:110022.
    

    >> Share

    
    
48. VERDUIJN GM, Sijtsema ND, van Norden Y, Heemsbergen WD, et al
    Response to the letter-to-the-editor "Comments on: Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment".
    Radiother Oncol. 2024;190:110036.
    

    >> Share

    
    
49. SOMAY E, Yilmaz B, Topkan E
    Comments on "Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment".
    Radiother Oncol. 2024;190:110035.
    

    >> Share

    
    
50. ZHU Y, Cheng J, Li Y, Pan D, et al
    Progression of cognitive dysfunction in NPC survivors with radiation-induced brain necrosis: A prospective cohort.
    Radiother Oncol. 2024;190:110033.
    

    >> Share

    
    
51. LIMKIN E, Blanchard P, Lacas B, Bourhis J, et al
    Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
    Radiother Oncol. 2024;190:110011.
    

    >> Share

    
    
52. RONCHI S, Cicchetti A, Bonora M, Ingargiola R, et al
    Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity.
    Radiother Oncol. 2024;190:110003.
    

    >> Share

    
    
53. MUMAW DA, Hazy AJ, Vayntraub A, Quinn TJ, et al
    Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group.
    Radiother Oncol. 2024;190:109977.
    

    >> Share

    
    
54. WANG X, Huang N, Yip PL, Wang J, et al
    The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-word study with a large population.
    Radiother Oncol. 2024;194:110154.
    

    >> Share

    
    
55. FIORINO C, Palumbo D, Mori M, Palazzo G, et al
    Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial.
    Radiother Oncol. 2024;194:110160.
    

    >> Share

    
    
56. BERBEE M, Muijs CT, Schuit E
    Response to letter to the editor regarding "External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts" by M. Berbee et al.
    Radiother Oncol. 2024 Feb 17:110176. doi: 10.1016/j.radonc.2024.110176.
    

    >> Share

    
    

    
    Thyroid

57. TARASOVA VD, Tsai J, Masannat J, Hernandez-Prera J, et al
    Characterization of the thyroid cancer genomic landscape by plasma-based circulating tumor DNA next-generation sequencing.
    Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0204.
    

    >> Share

    
    
58. FEI-ZHANG D, Verma R, Arimoto R, Lawrence AS, et al
    Social Vulnerability Association with Thyroid Cancer Disparities in the United States.
    Thyroid. 2023 Dec 9. doi: 10.1089/thy.2023.0370.
    

    >> Share

    
    
59. TAYLOR SR, Chiu AS, Hoxha I, Saucke MC, et al
    Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study.
    Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0479.
    

    >> Share

    
    
60. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
    Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
    

    >> Share

    
    
61. TRAN TV, Schonfeld SJ, Pasqual E, Haymart MR, et al
    All-cause and cause-specific mortality among low-risk differentiated thyroid cancer survivors in the United States.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0449.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share